Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)

Xuanzhu Biopharmaceutical Revenue

Xuanzhu Biopharmaceutical had revenue of 33.88M CNY in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 103.32M, up 223.31% year-over-year. In the year 2025, Xuanzhu Biopharmaceutical had annual revenue of 51.77M with 72.03% growth.

• Revenue (ttm): 103.32M CNY
• Revenue Growth: +223.31%
• P/S Ratio: 46.59
• Revenue / Employee: 302.11K CNY
• Employees: 342
• Market Cap: 5.56B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	51.77M	21.68M	72.03%
Dec 31, 2024	30.09M	30.07M	103,672.41%
Dec 31, 2023	29.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error